Amyloid heart disease occurs when amyloid fibrils build up in the heart, making it more difficult for the heart to pump blood around the body. Eventually, this can lead to heart failure. People can ...

Interviewer: Amyloidosis is a rare and possibly debilitating disease, which affects about 4,000 people a year in the United States. If left untreated, the disease can cause severe organ damage, so ...

Amyloidosis is classified into three main forms depending on the cause of the condition. The condition is also referred to as either localized when only one site of the body is affected, or systemic ...

HELIOS-B is a global, randomized, double-blind, placebo-controlled clinical trial that evaluated the efficacy and safety of AMVUTTRA (R) in adult patients with wtATTR or hATTR amyloidosis with ...

The National Institutes of Health has classified amyloidosis as a rare condition — one that affects fewer than 200,000 Americans. (1) While most experts who study the disease say it’s presumably much ...

Transthyretin amyloidosis typically presents with entrapment neuropathy, polyneuropathy or heart failure; some patients may experience autonomic dysfunction or symptoms of central nervous system ...

Amyloidosis comprises a group of diseases characterized by the extracellular deposition of insoluble fibrillar proteins. This mechanism generates different clinical syndromes depending on the site and ...

Wainua (eplontersen) is a prescription injection medicine that slows down nerve damage in people with a type of amyloidosis called hereditary transthyretin-mediated amyloidosis (hATTR). The FDA ...

THE FORMER Deputy First Minister of Northern Ireland Martin McGuinness died on March 21 2017. In January it was reported that he was suffering from amyloidosis. Ex Deputy First Minister for Northern ...

Multiple myeloma is an uncommon cancer affecting plasma cells in the bone marrow. Tumors in the bones and other organs can cause the cells to grow out of control. A complication of this cancer is ...